(Q53668896)

English

Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author name string

Subbi P Mathur

1

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

Rajesh S Mathur

2

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

Elizabeth A Gray

3

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

Derrick Lane

4

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

Paul G Underwood

5

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

Matthew Kohler

6

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

William T Creasman

7

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

98

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

3

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

467-483

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

Insulin-like growth factor II in gynecological cancers: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Lymphatics at the crossroads of angiogenesis and lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Lymphangiogenesis and tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Lymphangiogenesis and tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Expression and significance of VEGF-C and FLT-4 in gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

VEGF-C mediates cyclic pressure-induced endothelial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

In vitro downregulation of growth factors by insulin-like growth factor binding protein-3 in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.003

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.05.003

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/15982726

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53668896&oldid=2043364725"